Legislation · Canada (Federal) · Federal
C-272 — An Act to amend the Controlled Drugs and Substances Act (supervised drug consumption sites)
Clarion tracks C-272 before Canada (Federal) — its status, sponsor, plain-language summary, and every stage it moves through, each cited to the official record.
- Status
- Outside the order of precedence
- Sponsor
- Dan Mazier
- Introduced
- 2026-03-26
- Session
- 45-1
Policy areas
See what's moving in Canadian policy — get The Dispatch, our free weekly read.
What it does
AI plain-language summary of the official text.
Bill C-272 is a Private Member's Bill introduced in the House of Commons that proposes amendments to the Controlled Drugs and Substances Act relating to supervised drug consumption sites. The bill received first reading on March 26, 2026, and currently sits outside the Order of Precedence, meaning it has not yet been scheduled for further debate. No additional legislative progress has been made at this time.
Passage outlook
Unlikely to pass because it's a private member's bill (which rarely passes), it's outside the order of precedence.
Historically 0–5% of comparable federal bills became law (base rate 4%).
If this private member's bill would create new spending, it needs a Royal Recommendation (Cabinet only) — without one, passage is effectively nil.
A private member's bill's fate hinges on its position in the Order of Precedence (a random draw) — bills low on the list often run out of calendar time.
A transparent, rule-based outlook from bill type, stage, and verified government standing — not a guaranteed prediction.
Track C-272 — and everything like it
Set a topic, and Clarion grades the bills, debates, and lobbying filings it ingests to your files — with a calibrated passage forecast and an AI clerk that answers from the record and cites it.